Prior to joining Aldagen, Mr Carberry spent 27 years with Johnson & Johnson in a variety of financial leadership roles, including most recently as CFO of Johnson & Johnson’s Independence Technology subsidiary during the time that the company was commercializing its first products.
Tom Amick, chairman and CEO of Aldagen, said: “We are thrilled to have someone on board with Dave’s level of financial experience running mature businesses and dealing with many of the matters faced by companies like Aldagen, including commercialization and reimbursement activities. Dave also has significant business development and M&A experience which can be critical in this industry.”